Details for 2007840744
Up to date per 04.04.2026
Actions
Details for 2007840744
Granted/Registered
European Patent
17.06.2009 A
19.09.2012 B1
07.08.2006
US
836250 P
01.11.2006
US
856144 P
A61K 39/395 20060101AFI20090305BHEP
Owner
AbbVie Biotherapeutics Inc.1500 Seaport Boulevard Redwood City, CA 94063US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbH Wien
Inventor
AFAR, Daniel2882 Arlington Place Fremont, California 94555US
Information about Fees